These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10930855)

  • 41. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus.
    Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Espinosa G; Cervera R; Carmona F; Balsch J; Ingelmo M; Ordinas A
    Lupus; 2002; 11(11):730-5. PubMed ID: 12475003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.
    Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G
    Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anticardiolipin antibodies and ulcerations of the leg.
    Barbaud AM; Gobert B; Reichert S; Schmutz JL; Bene MC; Weber M; Faure GC
    J Am Acad Dermatol; 1994 Oct; 31(4):670-1. PubMed ID: 8089297
    [No Abstract]   [Full Text] [Related]  

  • 45. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Livedoid vasculopathy in a patient with factor V mutation (Leiden).
    Biedermann T; Flaig MJ; Sander CA
    J Cutan Pathol; 2000 Sep; 27(8):410-2. PubMed ID: 10955688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
    Simkova M; Simko F; Kovacs L
    Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [List of diagnostic tests and procedures in leg ulcer].
    Spoljar S
    Acta Med Croatica; 2013 Oct; 67 Suppl 1():21-8. PubMed ID: 24371972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosus.
    Bengtsson A; Zöller B; de Frutos PG; Dahlbäck B; Sturfelt G
    Lupus; 1996 Dec; 5(6):598-601. PubMed ID: 9116703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of the uterine and intraovarian arterial flows in nonpregnant women having a history of recurrent spontaneous miscarriage associated with antiphospholipid syndrome.
    Jirous J; Diejomaoh ME; Al-Abdulhadi F; Boland MH; Nazar M
    Arch Gynecol Obstet; 2004 Sep; 270(2):74-8. PubMed ID: 12827389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arteriovenous fistula thrombosis in patients on regular hemodialysis: a report of 171 patients.
    Roozbeh J; Serati AR; Malekhoseini SA
    Arch Iran Med; 2006 Jan; 9(1):26-32. PubMed ID: 16649374
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activated protein C resistance -- in the absence of factor V Leiden -- and pregnancy.
    Lindqvist PG; Svensson P; Dahlbäck B
    J Thromb Haemost; 2006 Feb; 4(2):361-6. PubMed ID: 16420566
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thrombophilia in patients with chronic venous leg ulcers-a study on patients with or without post-thrombotic syndrome.
    Zutt M; Krüger U; Rosenberger A; Schön MP; Neumann C; von Ahsen N; Kretschmer L
    J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1432-9. PubMed ID: 21392126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Activated protein C resistance in patients with venous leg ulcer].
    Munkvad S; Jørgensen M
    Ugeskr Laeger; 1997 Mar; 159(14):2100-2. PubMed ID: 9148535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identifying the source of superficial reflux in venous leg ulcers using duplex ultrasound.
    Obermayer A; Garzon K
    J Vasc Surg; 2010 Nov; 52(5):1255-61. PubMed ID: 20692796
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patients with persistent APC-resistance without factor V Leiden mutation.
    Schwarz T; Siegert G; Mikulin U; Gehrisch S; Runge E; Berg LP; Koch R; Schellong SM
    Vasa; 2001 Feb; 30(1):24-7. PubMed ID: 11284086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival advantage of heterozygous factor V Leiden carriers in murine sepsis.
    Kerschen E; Hernandez I; Zogg M; Maas M; Weiler H
    J Thromb Haemost; 2015 Jun; 13(6):1073-80. PubMed ID: 25690763
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Behaviour of the plasma concentration of gelatinases and their tissue inhibitors in subjects with venous leg ulcers.
    Caimi G; Ferrara F; Montana M; Muratori I; Amato C; Canino B; Lo Presti R; Hopps E
    Clin Hemorheol Microcirc; 2015; 60(3):309-16. PubMed ID: 25159491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Venous thromboembolic disease: risk factors and laboratory investigation.
    Alhenc-Gelas M; Aiach M; de Moerloose P
    Semin Vasc Med; 2001; 1(1):81-8. PubMed ID: 15199517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.